Main points in our study

Number of LTx recipients

Percentage

Total number of LTx recipients in our center

255

100%

COVID-19 cases classification

Number of COVID-19 cases

21

8.23%

Confirmed cases by PCR

17

80.5%

Suspected cased by labs and imaging

4

19%

Duration since Ltx

Long term survivors (> 12 months)

19

90.4%

Recent Ltx recipients (< 12 months)

2

9.5%

Graft function during COVID-19 infection

Stable

19

90%

Chronic rejection

1

4.7%

Biliary stricture

3

14.2%

Other comorbidities

Diabetes

2

9.5%

Hypertension

1

4.6%

Smoking

0

0%

Obesity

0

0%

Needs hospitalization?

Yes?

9

42.6%

 Oxygen therapy?

3

14.2%

 ICU admission?

1

4.6%

 Mechanical ventilation?

1

4.6%

 Inotropes/Renal replacement therapy

1

4.6%

No?

12

57%

WHO assesment scale (0 = no infection 1 = no limitation of activities 2 = limitation of activities 3 = hospitalized, no oxygen therapy 4 = oxygen by mask or nasal prong 5 = non-invasive ventilation or high-flow oxygen 6 = intubation and mechanical ventilation 7 = ventilation + additional organ support 8 = death)

1

6

28%

2

5

23%

3

7

33.3%

4

2

9.5%

7

1

4.6%

CT chest (0 = Normal 1 = Ground glass/consolidation 2 = Crazy paving 3 = Vascular thickening 4 = All those findings)

0

5

23%

1

4

19%

2

2

9.5%

3

3

14%

4

1

4.6%

5

6

28%

Outcome

Improved

20

95%

Mortality

1

4.6%

Immunosuppressive therapy

Stop

2

9.5%

Reduce dose

2

9.5%

Continue same dose

17

80%